Pharmascience Built a Generics Machine. Now It Wants Other Drugmakers to Hire It

The Montreal drugmaker is spending C$119.33 million to triple injectable capacity and sell its know-how to biotech companies. The bet turns an old factory discipline into a new growth engine - if quality and utilization keep pace.